AI Scribes and the Future of Clinical Trials

Artificial intelligence-powered scribes are rapidly transforming clinical documentation across healthcare settings, and their potential impact on clinical trials represents a particularly compelling opportunity for operational efficiency and data quality improvement. As clinical research continues to struggle with documentation burden, data collection challenges, and site efficiency issues, AI scribes offer the promise of streamlined workflows and enhanced data capture capabilities.

However, the integration of AI scribes into clinical trial environments introduces unique considerations around regulatory compliance, data integrity, and validation requirements that differ significantly from routine clinical care applications. The challenge lies in harnessing the efficiency benefits of AI-powered documentation while meeting the rigorous standards required for clinical research and regulatory submission.

Join us to discuss:

• How are AI scribes being adapted and validated for use in clinical trial environments, and what specific benefits are they delivering for site efficiency and data quality?
• What regulatory and compliance considerations are most critical when implementing AI scribes in clinical research, and how are organizations addressing these requirements?
• How might AI scribes reshape clinical trial operations, site workflows, and the investigator experience while maintaining data integrity and regulatory compliance?